Sanofi Down Over 7%, on Track for Largest Percent Decrease Since October 2023 -- Data Talk

Dow Jones
Aug 01, 2025

Sanofi SA Sponsored ADR $(SNY)$ is currently at $45.62, down $3.63 or 7.37%

 

--Would be lowest close since April 18, 2024, when it closed at $45.39

--On pace for largest percent decrease since Oct. 27, 2023, when it fell 19.13%

--Currently down five of the past six days

--Currently down four consecutive days; down 9.43% over this period

--Longest losing streak since June 18, 2025, when it fell for four straight trading days

--Worst four day stretch since the four days ending Nov. 1, 2023, when it fell 13.13%

--Down 5.57% month-to-date; on pace for worst month since May 2025, when it fell 10.15%

--Down 5.41% year-to-date

--Down 23.22% from its all-time closing high of $59.42 on March 6, 2025

--Down 11.69% from 52 weeks ago (Aug. 1, 2024), when it closed at $51.66

--Down 23.22% from its 52-week closing high of $59.42 on March 6, 2025

--Would be a new 52-week closing low

--Traded as low as $44.73; lowest intraday level since Oct. 30, 2023, when it hit $44.05

--Down 9.18% at today's intraday low; largest intraday percent decrease since Oct. 27, 2023, when it fell as much as 20.06%

 

All data as of 12:16:50 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

July 31, 2025 12:20 ET (16:20 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10